BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 31897192)

  • 1. Decreased expression of TXNIP predicts poor prognosis in patients with clear cell renal cell carcinoma.
    Gao Y; Qi JC; Li X; Sun JP; Ji H; Li QH
    Oncol Lett; 2020 Jan; 19(1):763-770. PubMed ID: 31897192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis.
    Fu Y; Sun S; Man X; Kong C
    PeerJ; 2019; 7():e7854. PubMed ID: 31592165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of
    Sun SS; Fu Y; Lin JY
    Oncol Lett; 2020 Apr; 19(4):2765-2772. PubMed ID: 32218829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma.
    Wang Y; Cong R; Liu S; Zhu B; Wang X; Xing Q
    Cancer Cell Int; 2021 Jan; 21(1):46. PubMed ID: 33430867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of lncRNA AGAP2-AS1 is an independent predictor of poor survival in patients with clear cell renal carcinoma.
    Gao L; Zhao A; Wang X
    Oncol Lett; 2020 Jun; 19(6):3993-4001. PubMed ID: 32382344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of PHYH for overall survival (OS) in clear cell renal cell carcinoma (ccRCC).
    Zhengqi Q; Zezhi G; Lei J; He Q; Jinyao P; Ying A
    Eur J Med Res; 2021 Jan; 26(1):9. PubMed ID: 33468235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma.
    Mu Z; Dong D; Sun M; Li L; Wei N; Hu B
    Front Oncol; 2020; 10():1566. PubMed ID: 33102202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased Expression of ACADSB Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma.
    Liu X; Zhang W; Wang H; Zhu L; Xu K
    Front Oncol; 2021; 11():762629. PubMed ID: 35096573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of MAX dimerization protein 3 (MXD3) predicts poor prognosis in clear cell renal cell carcinoma.
    Zhang F; Liu L; Wu P; Li S; Wei D
    Transl Androl Urol; 2021 Feb; 10(2):785-796. PubMed ID: 33718080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity.
    Liu S; Wang Y; Miao C; Xing Q; Wang Z
    Cancer Cell Int; 2021 Mar; 21(1):140. PubMed ID: 33648519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
    Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.
    Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ
    J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALDOB represents a potential prognostic biomarker for patients with clear cell renal cell carcinoma.
    Shao Y; Wu B; Yang Z; Liu Z; Ma Y; Huang H; Liu Y; Wang Z; Hu W; Wang Y; Niu Y
    Transl Androl Urol; 2023 Apr; 12(4):549-571. PubMed ID: 37181232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTPRO predicts patient prognosis and correlates with immune infiltrates in human clear cell renal cell carcinoma.
    Gan J; Zhang H
    Transl Cancer Res; 2020 Aug; 9(8):4800-4810. PubMed ID: 35117843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma.
    Zhang Y; Hua X; Shi H; Zhang L; Xiao H; Liang C
    Cancer Cell Int; 2021 Dec; 21(1):680. PubMed ID: 34923969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARα gene is a diagnostic and prognostic biomarker in clear cell renal cell carcinoma by integrated bioinformatics analysis.
    Luo Y; Chen L; Wang G; Qian G; Liu X; Xiao Y; Wang X; Qian K
    J Cancer; 2019; 10(10):2319-2331. PubMed ID: 31258735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
    Xu WH; Shi SN; Wang J; Xu Y; Tian X; Wan FN; Cao DL; Qu YY; Zhang HL; Ye DW
    Med Sci Monit; 2019 Dec; 25():9458-9470. PubMed ID: 31825950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Downregulation of Prognosis- and Immune Infiltration-Related Gene CYFIP2 Serves as a Novel Target in ccRCC.
    Tong J; Meng X; Lv Q; Yuan H; Li W; Xiao W; Zhang X
    Int J Gen Med; 2021; 14():6587-6599. PubMed ID: 34703279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma.
    Wang S; Ma X; Ying Y; Sun J; Yang Z; Li J; Jin K; Wang X; Xie B; Zheng X; Liu B; Xie L
    Cancer Cell Int; 2021 Jul; 21(1):341. PubMed ID: 34217271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.